{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T10:56:38Z","timestamp":1770980198821,"version":"3.50.1"},"reference-count":55,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T00:00:00Z","timestamp":1594944000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Currently, the first line treatment of persistent ductus arteriosus (PDA) is either indomethacin or ibuprofen. However, the potentially life-threatening side effects associated to their use have prompted physicians to look for alternative options. The incorporation of paracetamol as an alternative to ibuprofen in the management of PDA is still based on insufficient clinical evidence. Hence, more clinical trials are needed to establish a therapeutic role for paracetamol in the management of PDA that take into consideration short- and long-term safety and efficacy outcomes.<\/jats:p><jats:p><jats:bold>Study Design:<\/jats:bold> This is a non-inferiority, randomized, multicenter, double-blinded study to evaluate the efficacy, and safety of intravenous (IV) paracetamol vs. IV ibuprofen (standard treatment) for PDA in preterm patients with a gestational age \u2264 30 weeks. At baseline, patients will be randomized (1:1) to treatment with paracetamol or ibuprofen. The primary endpoint is closure of the ductus after the first treatment course. Secondary endpoints are related to effectiveness (need for a second treatment course, rescue treatment, reopening rate, time to definitive closure, need for surgical ligation), safety (early and long-term complications), pharmacokinetics, and pharmacodynamics, pharmacogenetics, pharmacoeconomics, and genotoxicity. Long-term follow-up to 24 months of corrected postnatal age will be performed using Bayley III neurodevelopmental scale.<\/jats:p><jats:p><jats:bold>Trial Registration:<\/jats:bold><jats:ext-link>ClinicalTrials.gov<\/jats:ext-link> Identifier: NCT04037514. EudraCT: 2015-003177-14.<\/jats:p>","DOI":"10.3389\/fped.2020.00372","type":"journal-article","created":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T09:19:37Z","timestamp":1594977577000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Paracetamol vs. Ibuprofen in Preterm Infants With Hemodynamically Significant Patent Ductus Arteriosus: A Non-inferiority Randomized Clinical Trial Protocol"],"prefix":"10.3389","volume":"8","author":[{"given":"Ana","family":"Garc\u00eda-Robles","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Gimeno Navarro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda del Mar","family":"Serrano Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Jos\u00e9","family":"P\u00e1rraga Quiles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Parra Llorca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Luis","family":"Poveda-Andr\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00e1ximo","family":"Vento Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Aguar Carrascosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,7,17]]},"reference":[{"key":"B1","first-page":"353","article-title":"Ductus arterioso persistente","volume-title":"Protoc Diagn\u00f3stico Ter AEP Neonatol.","author":"Gonz\u00e1lez","year":"2008"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1161\/CIRCULATIONAHA.105.592063","article-title":"Patent ductus arteriosus","volume":"114","author":"Schneider","year":"2006","journal-title":"Circulation."},{"key":"B3","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/S1084-2756(03)00121-0","article-title":"Treatment of patent ductus arteriosus","volume":"8","author":"Wyllie","year":"2003","journal-title":"Semin Neonatol SN."},{"key":"B4","doi-asserted-by":"publisher","first-page":"e20153730","DOI":"10.1542\/peds.2015-3730","article-title":"Patent ductus arteriosus in preterm infants","volume":"137","author":"Benitz","year":"2016","journal-title":"Pediatrics."},{"key":"B5","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.siny.2004.10.003","article-title":"The pharmacologic closure of the patent ductus arteriosus","volume":"10","author":"Bart Van Overmeire","year":"2005","journal-title":"Semin Fetal Amp Neonatal Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"F244","DOI":"10.1136\/adc.2006.104596","article-title":"Conservative treatment for patent ductus arteriosus in the preterm","volume":"92","author":"Vanhaesebrouck","year":"2007","journal-title":"Arch Dis Child Fetal Neonatal Ed."},{"key":"B7","doi-asserted-by":"publisher","first-page":"3975","DOI":"10.5812\/ijp.3975","article-title":"Comparison of oral acetaminophen versus ibuprofen in premature infants with patent ductus arteriosus","volume":"26","author":"Bagheri","year":"2016","journal-title":"Iran J Pediatr."},{"key":"B8","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3109\/14767058.2011.607593","article-title":"Renal safety of non steroidal anti inflammatory drugs (NSAIDs) in the pharmacologic treatment of patent ductus arteriosus","volume":"24","author":"Fanos","year":"2011","journal-title":"J Matern-Fetal Neonatal Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"263","DOI":"10.2174\/157488412803305830","article-title":"Pharmacological management of PDA: oral versus intravenous medications","volume":"7","author":"Demirel","year":"2012","journal-title":"Curr Clin Pharmacol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1007\/s00431-002-0915-y","article-title":"Safety and efficacy of ibuprofen versus indomethacin in preterm infants treated for patent ductus arteriosus: a randomised controlled trial","volume":"161","author":"Lago","year":"2002","journal-title":"Eur J Pediatr."},{"key":"B11","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1203\/00006450-200001000-00009","article-title":"Randomized double-blind controlled trial comparing the effects of ibuprofen with indomethacin on cerebral hemodynamics in preterm infants with patent ductus arteriosus","volume":"47","author":"Patel","year":"2000","journal-title":"Pediatr Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e1618","DOI":"10.1542\/peds.2011-0359","article-title":"Ductal closure with paracetamol: a surprising new approach to patent ductus arteriosus treatment","volume":"128","author":"Hammerman","year":"2011","journal-title":"Pediatrics."},{"key":"B13","doi-asserted-by":"publisher","first-page":"e77888","DOI":"10.1371\/journal.pone.0077888","article-title":"Comparison of oral paracetamol versus ibuprofen in premature infants with patent ductus arteriosus: a randomized controlled trial","volume":"8","author":"Dang","year":"2013","journal-title":"PLoS ONE."},{"key":"B14","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.jpeds.2013.11.008","article-title":"Oral paracetamol versus oral ibuprofen in the management of patent ductus arteriosus in preterm infants: a randomized controlled trial","volume":"164","author":"Oncel","year":"2014","journal-title":"J Pediatr."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.3109\/14767058.2013.871630","article-title":"Paracetamol effectiveness, safety and blood level monitoring during patent ductus arteriosus closure: a case series","volume":"27","author":"Kessel","year":"2014","journal-title":"J Matern Fetal Neonatal Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/pr.2014.82","article-title":"Efficacy of paracetamol on patent ductus arteriosus closure may be dose dependent: evidence from human and murine studies","volume":"76","author":"El-Khuffash","year":"2014","journal-title":"Pediatr Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1159\/000352068","article-title":"Is paracetamol a useful treatment for ibuprofen-resistant patent ductus arteriosus?","volume":"104","author":"Alan","year":"2013","journal-title":"Neonatology."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1017\/S1047951114001577","article-title":"Intravenous paracetamol with a lower dose is also effective for the treatment of patent ductus arteriosus in pre-term infants","volume":"25","author":"Tekg\u00fcnd\u00fcz","year":"2014","journal-title":"Cardiol Young."},{"key":"B19","doi-asserted-by":"publisher","first-page":"F94","DOI":"10.1136\/archdischild-2012-302044","article-title":"An alternative drug (paracetamol) in the management of patent ductus arteriosus in ibuprofen-resistant or contraindicated preterm infants","volume":"98","author":"Oncel","year":"2012","journal-title":"Arch Dis Child Fetal Neonatal Ed."},{"key":"B20","doi-asserted-by":"publisher","first-page":"312","DOI":"10.4103\/0022-3859.123164","article-title":"Oral paracetamol in treatment of closure of patent ductus arteriosus in preterm neonates","volume":"59","author":"Jasani","year":"2013","journal-title":"J Postgrad Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"30","DOI":"10.4103\/2249-4847.109245","article-title":"An interesting observation of PDA closure with oral paracetamol in preterm neonates","volume":"2","author":"Sinha","year":"2013","journal-title":"J Clin Neonatol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1007\/s00431-015-2541-5","article-title":"Limited effects of intravenous paracetamol on patent ductus arteriosus in very low birth weight infants with contraindications for ibuprofen or after ibuprofen failure","volume":"174","author":"Roofthooft","year":"2015","journal-title":"Eur J Pediatr."},{"key":"B23","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1007\/s00246-013-0770-9","article-title":"Paracetamol therapy for patent ductus arteriosus in premature infants: a chance before surgical ligation","volume":"35","author":"Ozdemir","year":"2014","journal-title":"Pediatr Cardiol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1038\/jp.2014.96","article-title":"Paracetamol treatment of patent ductus arteriosus in preterm infants","volume":"34","author":"Nadir","year":"2014","journal-title":"J Perinatol Off J Calif Perinat Assoc."},{"key":"B25","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.anpedi.2014.07.018","article-title":"El paracetamol podr\u00eda ser \u00fatil en el tratamiento del ductus arterioso persistente en el reci\u00e9n nacido de muy bajo peso","volume":"82","author":"P\u00e9rez","year":"2015","journal-title":"An Pediatr\u00eda."},{"key":"B26","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3109\/14767058.2014.989829","article-title":"Oral versus intravenous paracetamol: which is better in closure of patent ductus arteriosus in very low birth weight infants?","volume":"29","author":"Sancak","year":"2016","journal-title":"J Matern Fetal Neonatal Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.3892\/etm.2016.3676","article-title":"Oral paracetamol vs. oral ibuprofen in the treatment of symptomatic patent ductus arteriosus in premature infants: a randomized controlled trial","volume":"12","author":"Yang","year":"2016","journal-title":"Exp Ther Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s13312-015-0677-z","article-title":"Enteral paracetamol or intravenous indomethacin for closure of patent ductus arteriosus in preterm neonates: a randomized controlled trial","volume":"52","author":"Dash","year":"2015","journal-title":"Indian Pediatr."},{"key":"B29","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1177\/0300060517722698","article-title":"Oral paracetamol versus oral ibuprofen for treatment of patent ductus arteriosus","volume":"46","author":"Al-lawama","year":"2018","journal-title":"J Int Med Res."},{"key":"B30","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s00431-016-2830-7","article-title":"Comparative study of the efficacy and safety of paracetamol, ibuprofen, and indomethacin in closure of patent ductus arteriosus in preterm neonates","volume":"176","author":"El-Mashad","year":"2017","journal-title":"Eur J Pediatr."},{"key":"B31","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.jpeds.2020.01.058","article-title":"Oral paracetamol vs oral ibuprofen in patent ductus arteriosus: a randomized, controlled, noninferiority trial","volume":"222","author":"Kumar","year":"2020","journal-title":"J. Pediatr."},{"key":"B32","doi-asserted-by":"publisher","first-page":"F127","DOI":"10.1136\/archdischild-2014-307312","article-title":"Paracetamol for the treatment of patent ductus arteriosus in preterm neonates: a systematic review and meta-analysis","volume":"101","author":"Terrin","year":"2016","journal-title":"Arch Dis Child Fetal Neonatal Ed."},{"key":"B33","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.1080\/14767058.2017.1338263","article-title":"Paracetamol versus ibuprofen for the treatment of patent ductus arteriosus in preterm neonates: a meta-analysis of randomized controlled trials","volume":"31","author":"Huang","year":"2018","journal-title":"J Matern-Fetal Neonatal Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1053\/j.semperi.2018.05.007","article-title":"Evidence-based use of acetaminophen for hemodynamically significant ductus arteriosus in preterm infants","volume":"42","author":"Jasani","year":"2018","journal-title":"Semin Perinatol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"CD010061","DOI":"10.1002\/14651858.CD010061.pub3","article-title":"Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low birth weight infants","volume":"4","author":"Ohlsson","year":"2018","journal-title":"Cochrane Database Syst Rev."},{"key":"B36","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.clp.2015.11.008","article-title":"Recent advances in the treatment of preterm newborn infants with patent ductus arteriosus","volume":"43","author":"Sallmon","year":"2016","journal-title":"Clin Perinatol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1159\/000345337","article-title":"Intravenous paracetamol treatment in the management of patent ductus arteriosus in extremely low birth weight infants","volume":"103","author":"Oncel","year":"2013","journal-title":"Neonatology."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1007\/s00280-015-2729-4","article-title":"Validation of a fast and low-cost alkaline lysis method for gDNA extraction in a pharmacogenetic context","volume":"75","author":"Ramos-D\u00edaz","year":"2015","journal-title":"Cancer Chemother Pharmacol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"030201","DOI":"10.11613\/BM.2017.030201","article-title":"Dealing with the positive publication bias: Why you should really publish your negative results","volume":"27","author":"Mlinari\u0107","year":"2017","journal-title":"Biochem Medica."},{"key":"B40","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1186\/s13063-015-0920-x","article-title":"Risk of selection bias in randomised trials","volume":"16","author":"Kahan","year":"2015","journal-title":"Trials."},{"key":"B41","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1080\/17425255.2018.1492550","article-title":"The dark side of ibuprofen in the treatment of patent ductus arteriosus: could paracetamol be the solution?","volume":"14","author":"Cuzzolin","year":"2018","journal-title":"Expert Opin Drug Metab Toxicol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"e000143","DOI":"10.1136\/bmjpo-2017-000143","article-title":"Oral paracetamol versus oral ibuprofen for closure of haemodynamically significant patent ductus arteriosus in preterm neonates (<32 weeks): a blinded, randomised, active-controlled, non-inferiority trial","volume":"1","author":"Kumar","year":"2017","journal-title":"BMJ Paediatr Open."},{"key":"B43","doi-asserted-by":"publisher","first-page":"676192","DOI":"10.1155\/2013\/676192","article-title":"Patent ductus arteriosus in preterm infants: do we have the right answers?","volume":"2013","author":"Abdel-Hady","year":"2013","journal-title":"BioMed Res Int."},{"key":"B44","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jpeds.2016.06.034","article-title":"Acetaminophen to prevent symptomatic patent ductus arteriosus: another drug bites the dust?","volume":"177","author":"Anker","year":"2016","journal-title":"J Pediatr."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1438038","DOI":"10.1155\/2017\/1438038","article-title":"Paracetamol in patent ductus arteriosus treatment: efficacious and safe?","volume":"2017","author":"Bardanzellu","year":"2017","journal-title":"BioMed Res Int."},{"key":"B46","doi-asserted-by":"publisher","first-page":"e394","DOI":"10.1542\/neo.19-7-e394","article-title":"Diagnosis and management of patent ductus arteriosus","volume":"19","author":"Gillam-Krakauer","year":"2018","journal-title":"NeoRev."},{"key":"B47","doi-asserted-by":"publisher","first-page":"F424","DOI":"10.1136\/adc.2007.118117","article-title":"Towards rational management of the patent ductus arteriosus: the need for disease staging","volume":"92","author":"McNamara","year":"2007","journal-title":"Arch Dis Child Fetal Neonatal Ed."},{"key":"B48","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.curtheres.2014.12.001","article-title":"Clinical pharmacology of paracetamol in neonates: a review","volume":"77","author":"Pacifici","year":"2015","journal-title":"Curr Ther Res."},{"key":"B49","unstructured":"Ficha t\u00e9cnica-Paracetamol Combino Pharm 10 mg\/ml soluci\u00f3n para perfusi\u00f3n EFG2010"},{"key":"B50","doi-asserted-by":"publisher","first-page":"825","DOI":"10.3109\/14767058.2012.755162","article-title":"A different first-choice drug in the medical management of patent ductus arteriosus: oral paracetamol","volume":"26","author":"Yurttutan","year":"2012","journal-title":"J Matern Fetal Neonatal Med."},{"key":"B51","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.jpeds.2018.01.024","article-title":"Paracetamol serum concentrations in neonates treated enterally for ductal closure: a pilot study","volume":"198","author":"Bin-Nun","year":"2018","journal-title":"J Pediatr."},{"key":"B52","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/chd.12715","article-title":"Pharmacotherapy for patent ductus arteriosus closure","volume":"14","author":"Ferguson","year":"2019","journal-title":"Congenit Heart Dis."},{"key":"B53","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1159\/000365029","article-title":"A systematic review of paracetamol closure of patent ductus arteriosus: ready for prime time?","volume":"18","author":"Hammerman","year":"2015","journal-title":"Pediat Adol Med."},{"key":"B54","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1111\/j.1533-2500.2012.00556.x","article-title":"Plasma and cerebrospinal fluid pharmacokinetic parameters after single-dose administration of intravenous, oral, or rectal acetaminophen","volume":"12","author":"Singla","year":"2012","journal-title":"Pain Pract."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1093\/ajcn\/61.5.1067","article-title":"L-cysteine and glutathione metabolism are impaired in premature infants due to cystathionase deficiency","volume":"61","author":"Vi\u00f1a","year":"1995","journal-title":"Am J Clin Nutr."}],"updated-by":[{"DOI":"10.3389\/fped.2021.834454","type":"corrigendum","label":"Corrigendum","source":"publisher","updated":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T00:00:00Z","timestamp":1642032000000}}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2020.00372\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T12:18:51Z","timestamp":1642076331000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2020.00372\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,17]]},"references-count":55,"alternative-id":["10.3389\/fped.2020.00372"],"URL":"https:\/\/doi.org\/10.3389\/fped.2020.00372","relation":{"corrigendum":[{"id-type":"doi","id":"10.3389\/fped.2021.834454","asserted-by":"object"}]},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,17]]},"article-number":"372"}}